Pubfacts - Scientific Publication Data
  • Categories
  • |
  • Journals
  • |
  • Authors
  • Login
  • Categories
  • Journals

Search Our Scientific Publications & Authors

Publications
  • Publications
  • Authors
find publications by category +
Translate page:

Concurrent Validity and Prognostic Utility of the Needs Assessment Tool: Progressive Disease Heart Failure.

Authors:
Chloe King Assem Khamis Joy Ross Fliss E M Murtagh Miriam J Johnson Christina Ramsenthaler

J Pain Symptom Manage 2022 05 23;63(5):635-644.e3. Epub 2022 Jan 23.

Wolfson Palliative Care Research Center (C.K., A.K.,F.E.M.M.,M.J.J.,C.R., Hull York Medical School, University of Hull, Hull, UK; Cicely Saunders Institute of Palliative Care, Policy and Rehabilitation (F.E.M.M.,C.R.), King's College London, London, UK; School of Health Professions, Institute of Nursing (C.R.), Zurich University of Applied Sciences, Winterthur, Switzerland. Electronic address:

Context: People with advanced heart failure have supportive and palliative needs requiring systematic assessment.

Objectives: We aimed to assess the validity of the Needs Assessment Tool: Progressive Disease - Heart Failure (NAT:PD-HF).

Methods: Secondary analysis of routinely collected patient data from a specialist palliative care-heart disease service improvement project. NAT:PD-HF, the Integrated Palliative care Outcome Scale (IPOS), and patient and/or carer-report data were collected. Concurrent validity between NAT:PD-HF items and comparison measures (Kendall's tau; kappa); construct validity via known-group comparisons; predictive utility of NAT:PD-HF for survival (multivariable Cox hazard regression model).

Results: Data from 88 patients (50% men; mean age 85; median survival 205 days; 64% left ventricular systolic dysfunction) were analyzed. Prevalence- and bias-adjusted kappa values indicated moderate agreement for physical symptom needs (k: 0.33 for patients, 0.42 for carers). Substantial agreement was observed for patient and/or carer psychological symptoms, and information needs (k ≥ 0.6). NAT:PD-HF distinguished between patients with different survival, comorbidities, functional scores, and palliative Phase of Illness with moderate to high effect sizes. NAT did not predict survival when adjusted for mortality risk score and functional status (2+ needs HR: 1.52, 95% CI: 1.01-1.74).

Conclusion: The NAT:PD-HF is a valid tool for clinician assessment of physical, psychosocial, and information patient and/or carer needs.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jpainsymman.2022.01.014DOI Listing
May 2022

Publication Analysis

Top Keywords

patient and/or
12
heart failure
12
progressive disease
8
disease heart
8
concurrent validity
8
and/or carer
8
assessment tool
8
tool progressive
8
natpd-hf
5
survival 205
4
205 days
4
days 64%
4
64% left
4
left ventricular
4
ventricular systolic
4
psychosocial patient
4
systolic dysfunction
4
age median
4
dysfunction analyzed
4
analyzed prevalence-
4

Keyword Occurance

Similar Publications

Using Kotter's 8 Steps of Change to Tackle Over-fasting of children attending day surgery.

Authors:
Su Ying Ong Alyson Walker

Paediatr Anaesth 2022 May 22. Epub 2022 May 22.

Consultant paediatric cardiac anaesthetist, Royal Hospital for Children, Glasgow.

Over-fasting before surgery can lead to dehydration, irritability, lethargy, nausea, hypoglycaemia, tricky intravenous cannulation and decreased patient satisfaction . We used 'Kotter's 8 steps for change' as an approach to tackling the problem of over-fasting in our day surgery unit . Using a video of a patient's experience with overfasting we created a sense of urgency and need for change (Step1: create urgency). Read More

View Article and Full-Text PDF
May 2022
Similar Publications

Autoantibodies against apolipoprotein A-1 after COVID-19 predict symptoms persistence.

Authors:
Arnaud G L'Huillier Sabrina Pagano Stephanie Baggio Benjamin Meyer Diego O Andrey Mayssam Nehme Idris Guessous Christiane S Eberhardt Angela Huttner Klara M Posfay-Barbe Sabine Yerly Claire-Anne Siegrist Laurent Kaiser Nicolas Vuilleumier

Eur J Clin Invest 2022 May 22:e13818. Epub 2022 May 22.

Division of Laboratory Medicine, Department of Diagnostics and of Medical Specialties, Geneva University Hospitals and Geneva University, Geneva, Switzerland.

Background: SARS-CoV-2 infection triggers different auto-antibodies, including anti-apolipoprotein A-1 IgGs (AAA1), which could be of concern as mediators of persistent symptoms. We determined the kinetics of AAA1 response over after COVID-19, and the impact of AAA1 on the inflammatory response and symptoms persistence.

Methods: All serologies were assessed at one, three, six, and twelve months in 193 hospital employees with COVID-19. Read More

View Article and Full-Text PDF
May 2022
Similar Publications

Epidemiology of dermatomycoses and onychomycoses in Ireland (2001 to 2020): A single-institution review.

Authors:
James Powell Emma Porter Sinead Field Nuala O'Connell Kieran Carty Colum P Dunne

Mycoses 2022 May 22. Epub 2022 May 22.

School of Medicine and Centre for Interventions in Infection, Inflammation, and Immunity (4i), University of Limerick, Limerick, Ireland.

Background: Fungal skin infections are recognised as one of the most common health disorders globally, and dermatophyte infections of the skin, hair and nails are the most common fungal infections. Dermatophytes can be classified as anthropophilic, zoophilic or geophilic species based on their primary habitat association, and this classification makes epidemiological analysis useful for prevention and control of these infections. The Irish contribution to the epidemiology of these infections has been scant, with just two papers (both reporting paediatric tinea capitis only) published in the last 20 years, and none in the last seven. Read More

View Article and Full-Text PDF
May 2022
Similar Publications

Global Longitudinal Strain by CMR Improves Prognostic Stratification in Acute Myocarditis presenting with Normal LVEF.

Authors:
Aldostefano Porcari Marco Merlo Chiara Baggio Giulia Gagno Marco Cittar Giulia Barbati Alessia Paldino Matteo Castrichini Giancarlo Vitrella Lorenzo Pagnan Antonio Cannatà Alessandro Andreis Annagrazia Cecere Alberto Cipriani Anne Raafs Daniel I Bromage Stefania Rosmini Paul Scott Daniel Sado Gianluca Di Bella Nucifora Gaetano Martina Perazzolo Marra Stephane Heymans Massimo Imazio Gianfranco Sinagra

Eur J Clin Invest 2022 May 22:e13815. Epub 2022 May 22.

Centre for Diagnosis and Treatment of Cardiomyopathies, Cardiovascular Department, Azienda Sanitaria Universitaria Giuliano-Isontina (ASUGI) and University of Trieste, Trieste, Italy.

Background: Prognostic stratification of acute myocarditis (AM) presenting with normal left ventricular ejection fraction (LVEF) relies mostly on late gadolinium enhancement (LGE) characterization. Left ventricular peak global longitudinal strain (LV-GLS) measured by feature tracking analysis might improve prognostication of AM presenting with normal LVEF.

Methods: Data of patients undergoing cardiac magnetic resonance (CMR) for clinically suspected AM in seven European Centres (2013-2020) were retrospectively analysed. Read More

View Article and Full-Text PDF
May 2022
Similar Publications

Nasopharyngeal cancer cell-derived exosomal PD-L1 inhibits CD8+ T cell activity and promotes immune escape.

Authors:
Jie Yang Jierong Chen Hu Liang Yahui Yu

Cancer Sci 2022 May 22. Epub 2022 May 22.

Department of Radiation Oncology, Zhujiang Hospital, Southern Medical University, Guangzhou, P. R. China.

Programmed cell death ligand 1 (PD-L1) is an immune surface protein that binds to programmed cell death 1 (PD-1) and allows tumors to evade T cell immunity. This study aims to define the role of PD-L1 shuttled by tumor cell-derived exosomes in the immune escape of nasopharyngeal carcinoma (NPC). PD-L1 expression was determined in the exosomes isolated from the plasma of NPC patients or from NPC cells. Read More

View Article and Full-Text PDF
May 2022
Similar Publications
}
© 2022 PubFacts.
  • About PubFacts
  • Privacy Policy
  • Sitemap